FDA Releases Final Guidance on Combination Drugs

The FDA has released final guidance on codevelopment of two or more investigational drugs. Taking heed of industry comments, the document expands the definition of “codevelopment” and clarifies criteria for when codevelopment is an appropriate development option.
Clinical Trials Advisor